One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
The cTnI/cTnT Ratio in Myocardial Injury: A Multicohort and Experimental Synthesis
High-Sensitivity Troponin I-to-High-Sensitivity Troponin T Ratio in Myocardial Injury: Old Dogs, New Tricks
Reframing the Next Era of Advancing Outcomes Following Acute Myocardial Infarction: The Need to Improve Diagnosis
High-Sensitivity Cardiac Troponin T-gen6 Assay in Suspected Myocardial Infarction: Diagnostic Accuracy, Cutoffs, and Clinical Implications
Passing the Torch?: A Next-Generation High-Sensitivity Cardiac Troponin T Assay
Comparison of the European Society of Cardiology 0/1-Hour and High-Sensitivity Troponin in the Evaluation of Patients With Suspected Acute Coronary Syndrome 0/2- or 0/3-Hour Algorithms for Rapid Myocardial Infarction Diagnosis: A Prospective Multicenter Study
Optimizing Approaches to Detect Patients With NSTEMI With Accelerated Diagnostic Protocols in the Emergency Department Setting
Cardiovascular Risk Across Myocardial Injury and Infarction Categories Using the Universal Definition: An Individual Patient-Level Data Meta-Analysis
Rethinking Cardiovascular Risk Across the Universal Definition: A Call to Reconsider Prognosis and Care
Cardiac Arrest and Outcome in Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction: A Pooled Analysis of Randomized Controlled Trials
Effect of Tocilizumab on Pro–B-Type Natriuretic Peptide and Infarct Size in Patients With Acute Myocardial Infarction at Risk of Cardiogenic Shock (DOBERMANN-T)
Effect of Low-Dose Dobutamine Infusion on N-Terminal Pro–B-Type Natriuretic Peptide in At-Risk Patients With Acute Myocardial Infarction (DOBERMANN-D): A Randomized Clinical Trial
DOBERMANN and the Preshock Window: Can We Intervene Before the “Bite?�
Digital Cognitive Behavioral Therapy for Cardiac Anxiety After Myocardial Infarction: Effects on Disease-Specific Health Status—Randomized Trial Results
Digital Interventions for Postmyocardial Infarction Cardiac Anxiety: Treating an Unmet Need, But Are They Accessible?
Financial Assistance Policies to Improve Post-Myocardial Infarction Care
Transforming Cardiovascular Leadership Through Strategic Investment
Hemodynamic Patterns During Veno-Arterial Extracorporeal Membrane Oxygen Flow Ramp Testing in Cardiogenic Shock
REPLY: Beyond PAPO-Flow: Insights From a Simple Hemodynamic Maneuver
